Long-term delayed emergence after remimazolam-based general anesthesia: a case report.
Tsubasa TakemoriYoshimasa OyamaTakenori MakinoSeigo HidakaTakaaki KitanoPublished in: JA clinical reports (2022)
Remimazolam is a short-acting anesthetic, but long-term delayed emergence with re-sedation may occur even after flumazenil administration. Anesthesia using remimazolam requires anesthesia management that takes into account the individual differences in sensitivity and metabolism, with BIS as the indicator.